A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has ...
Zacks Investment Research on MSN
ImmunityBio shares surge on updated durable lymphoma study results
Shares of ImmunityBio IBRX surged 39.8% on Friday and added a further 9.4% in after-hours trading after the company reported ...
Pharmacy shelves and online marketplaces these days are crowded with products that promise to “boost” your immunity. From ...
Clinical Trials Arena on MSN
ImmunityBio’s allogeneic CD19 cell therapy shows complete response beyond 15 months
ImmunityBio’s stock is up after its off-the-shelf allogeneic CD19 chimeric antigen receptor natural killer cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback